180 related articles for article (PubMed ID: 12165495)
1. Role of B7 costimulatory molecules in the adjuvant activity of the heat-labile enterotoxin of Escherichia coli.
Martin M; Sharpe A; Clements JD; Michalek SM
J Immunol; 2002 Aug; 169(4):1744-52. PubMed ID: 12165495
[TBL] [Abstract][Full Text] [Related]
2. Genetically manipulated bacterial toxin as a new generation mucosal adjuvant.
Yamamoto M; McGhee JR; Hagiwara Y; Otake S; Kiyono H
Scand J Immunol; 2001 Mar; 53(3):211-7. PubMed ID: 11251876
[TBL] [Abstract][Full Text] [Related]
3. Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) T cells.
Martin M; Hajishengallis G; Metzger DJ; Michalek SM; Connell TD; Russell MW
Infect Immun; 2001 Jan; 69(1):252-61. PubMed ID: 11119513
[TBL] [Abstract][Full Text] [Related]
4. Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production.
Brereton CF; Sutton CE; Ross PJ; Iwakura Y; Pizza M; Rappuoli R; Lavelle EC; Mills KH
J Immunol; 2011 May; 186(10):5896-906. PubMed ID: 21490151
[TBL] [Abstract][Full Text] [Related]
5. Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity.
Ryan EJ; McNeela E; Pizza M; Rappuoli R; O'Neill L; Mills KH
J Immunol; 2000 Nov; 165(10):5750-9. PubMed ID: 11067933
[TBL] [Abstract][Full Text] [Related]
6. Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.
Nawar HF; Arce S; Russell MW; Connell TD
Infect Immun; 2007 Feb; 75(2):621-33. PubMed ID: 17118982
[TBL] [Abstract][Full Text] [Related]
7. Direct effects on antigen-presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant.
Yamamoto M; Kiyono H; Yamamoto S; Batanero E; Kweon MN; Otake S; Azuma M; Takeda Y; McGhee JR
J Immunol; 1999 Jun; 162(12):7015-21. PubMed ID: 10358143
[TBL] [Abstract][Full Text] [Related]
8. Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat-labile enterotoxin.
De Haan L; Holtrop M; Verweij WR; Agsteribbe E; Wilschut J
Immunology; 1999 Aug; 97(4):706-13. PubMed ID: 10457227
[TBL] [Abstract][Full Text] [Related]
9. Dendritic Cell-Mediated Mechanisms Triggered by LT-IIa-B
Lee CH; Hajishengallis G; Connell TD
J Microbiol Biotechnol; 2017 Apr; 27(4):709-717. PubMed ID: 28144014
[TBL] [Abstract][Full Text] [Related]
10. Enterotoxin adjuvants have direct effects on T cells and antigen-presenting cells that result in either interleukin-4-dependent or -independent immune responses.
Yamamoto M; Kiyono H; Kweon MN; Yamamoto S; Fujihashi K; Kurazono H; Imaoka K; Bluethmann H; Takahashi I; Takeda Y; Azuma M; McGhee JR
J Infect Dis; 2000 Jul; 182(1):180-90. PubMed ID: 10882596
[TBL] [Abstract][Full Text] [Related]
11. TLR2-dependent modulation of dendritic cells by LT-IIa-B5, a novel mucosal adjuvant derived from a type II heat-labile enterotoxin.
Lee CH; Masso-Welch P; Hajishengallis G; Connell TD
J Leukoc Biol; 2011 Nov; 90(5):911-21. PubMed ID: 21791597
[TBL] [Abstract][Full Text] [Related]
12. Cholera toxin and Escherichia coli heat-labile enterotoxin, but not their nontoxic counterparts, improve the antigen-presenting cell function of human B lymphocytes.
Negri DR; Pinto D; Vendetti S; Patrizio M; Sanchez M; Riccomi A; Ruggiero P; Del Giudice G; De Magistris MT
Infect Immun; 2009 May; 77(5):1924-35. PubMed ID: 19223474
[TBL] [Abstract][Full Text] [Related]
13. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.
Verweij WR; de Haan L; Holtrop M; Agsteribbe E; Brands R; van Scharrenburg GJ; Wilschut J
Vaccine; 1998 Dec; 16(20):2069-76. PubMed ID: 9796066
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antigen uptake by dendritic cells induced by the B pentamer of the type II heat-labile enterotoxin LT-IIa requires engagement of TLR2.
Lee CH; Nawar HF; Mandell L; Liang S; Hajishengallis G; Connell TD
Vaccine; 2010 May; 28(21):3696-705. PubMed ID: 20332049
[TBL] [Abstract][Full Text] [Related]
15. The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT).
Cheng E; Cárdenas-Freytag L; Clements JD
Vaccine; 1999 Aug; 18(1-2):38-49. PubMed ID: 10501233
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli.
Liang S; Hosur KB; Nawar HF; Russell MW; Connell TD; Hajishengallis G
Vaccine; 2009 Jul; 27(32):4302-8. PubMed ID: 19450646
[TBL] [Abstract][Full Text] [Related]
17. Effects of LT-K63 and CpG2006 on phenotype and function of murine neonatal lymphoid cells.
Olafsdottir TA; Hannesdottir SG; Giudice GD; Trannoy E; Jonsdottir I
Scand J Immunol; 2007 Oct; 66(4):426-34. PubMed ID: 17850587
[TBL] [Abstract][Full Text] [Related]
18. Modulation of dendritic cell endocytosis and antigen processing pathways by Escherichia coli heat-labile enterotoxin and mutant derivatives.
Petrovska L; Lopes L; Simmons CP; Pizza M; Dougan G; Chain BM
Vaccine; 2003 Mar; 21(13-14):1445-54. PubMed ID: 12615441
[TBL] [Abstract][Full Text] [Related]
19. The LTR72 mutant of heat-labile enterotoxin of Escherichia coli enhances the ability of peptide antigens to elicit CD4(+) T cells and secrete gamma interferon after coapplication onto bare skin.
Beignon AS; Briand JP; Rappuoli R; Muller S; Partidos CD
Infect Immun; 2002 Jun; 70(6):3012-9. PubMed ID: 12010992
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity.
Dickinson BL; Clements JD
Infect Immun; 1995 May; 63(5):1617-23. PubMed ID: 7729864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
